Sanofi Pasteur Head: Global Flu Vaccination Rates 'Dangerously Low'
The head of Sanofi Pasteur tells Scrip more countries need to emulate the UK’s relatively high flu vaccination level, and expresses worries over China’s very low coverage.
You may also be interested in...
Evotec is building a gene therapy R&D center manned by ex-Takeda scientists and has already landed a multi-year drug discovery pact for it with their former Japanese employer.
The Global AMR R&D Hub’s newly launched Dynamic Dashboard aims to be “a comprehensive knowledge center for AMR R&D and market reforms,” its head tells Scrip.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.